IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells

Olivier Fesneau, Kimberly A. Samson, Wesley Rosales, Bretton Jones, Tarsem Moudgil, Bernard A. Fox, Venkatesh Rajamanickam, Thomas Duhen · 2024

Read IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells by Olivier Fesneau, Kimberly A. Samson, Wesley Rosales, Bretton Jones, Tarsem Moudgil, Bernard A. Fox, Venkatesh Rajamanickam, Thomas Duhen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574270.txt.

Description

A brake on killer T cells turns out to be switched on by a signal meant to help them, and a 2024 study by Olivier Fesneau and co-authors traces that loop. The brake is a receptor called NKG2A, and blocking it is a live strategy for freeing anti-tumor responses.

Working with T cells from head and neck and colorectal cancers, the team found the receptor appears as killer cells mature into a tumor-reactive type. Those cells share target signatures with their receptor-free kin, so they are not a separate army. The signal IL-12 proved essential for switching the receptor on, with help from a cell-contact pair and the cell's target sensor. The findings expose a feedback loop in which a helpful signal also arms the brake.

Catalog record

CREATOROlivier Fesneau, Kimberly A. Samson, Wesley Rosales, Bretton Jones, Tarsem Moudgil, Bernard A. Fox, Venkatesh Rajamanickam, Thomas Duhen
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11574270

Browse the full library · About the Tower of Babel